The LISI Group achieved record sales of more than €900 million in H1 2024 and improved its main financial indicators in line with the targets

•  Record sales up 10.0%, reflecting in particular the strong ramp-ups across all segments of the aerospace market

•  1.5 point improvement in current operating margin to 6.0%

•  Free Cash Flow recovery of +€28.5 million, thanks to strong growth in self-financing capacity despite the business acceleration and the maintenance of strategic inventories

•  Outlook: annual targets are confirmed in a volatile environment

LISI AEROSPACE

•  Strong activity across all segments of the aerospace market driven by the good performance of global air traffic

•  Gradual improvement in industrial productivity after the high level of recruitment in 2023

•  Negative Free Cash Flow, reflecting the increase in working capital requirements to respond to the significant increase in activity in a context of tensions in the supply chain

LISI AUTOMOTIVE

•  Good resilience in the face of the decline in global production of the division's customers

•  Market share gains maintain their momentum

•  Significant efforts to adapt to recent declines in demand which are weighing on key financial indicators

•  Positive Free Cash Flow with inventory levels under control

LISI MEDICAL (11 % of total consolidated sales)

•  Stability of sales with catch-up in H2 compared to H1

•  Operating margin suffered the adverse effects of inventory adjustments in the supply chain at the beginning of the first half-year

•  Free Cash Flow still positive with high CAPEX levels

OUTLOOK

The aeronautical development plan supports the Group's dynamics with excellent visibility.

Based on the performance of the first half, the Group confirms the objective set on February 22, 2024 when publishing the 2023 annual results, namely the improvement of its main benchmark financial indicators: EBIT and Free Cash Flow.